Pacific Biosciences of California, Inc. (PACB)

NASDAQ · Healthcare

Total Assets Cash on Hand Long Term Debt Total Liabilities Shareholder Equity

Pacific Biosciences of California, Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

Pacific Biosciences of California, Inc. shareholder equity for the quarter ending December 31, 2025 were 5.3M, a 98.94% decrease year-over-year.
Pacific Biosciences of California, Inc. shareholder equity for 2025 were 5.3M, a 98.94% decrease from 2024.
Pacific Biosciences of California, Inc. shareholder equity for 2024 were 506.6M, a 27.76% decrease from 2023.
Pacific Biosciences of California, Inc. shareholder equity for 2023 were 701.3M, a 24.59% increase from 2022.
Pacific Biosciences of California, Inc. shareholder equity for 2022 were 562.9M.

Shareholder Equity

QUARTERLY · $B

YOY QUARTERLY GROWTH · %

Pacific Biosciences of California, Inc. Annual Shareholder Equity (Millions of US $)
2025	$5
2024	$507
2023	$701
2022	$563
2021	$791
2020	$335
2019	$55
2018	$114
2017	$86
2016	$85
2015	$74
2014	$55
2013	$69
2012	$109
2011	$191

Pacific Biosciences of California, Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31	$5
2024-12-31	$507
2023-12-31	$701
2022-12-31	$563
2021-12-31	$791
2020-12-31	$335
2019-12-31	$55
2018-12-31	$114
2017-12-31	$86
2016-12-31	$85
2015-12-31	$74
2014-12-31	$55
2013-12-31	$69
2012-12-31	$109
2011-12-31	$191
2010-12-31	$280

Pacific Biosciences of California, Inc. Shareholder Equity — FAQ

Pacific Biosciences of California, Inc. (PACB) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see PACB's shareholder equity history?

The chart and table above show Pacific Biosciences of California, Inc.'s shareholder equity by year and by quarter, including the growth rate.